# Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

> **NCT00943709** · PHASE3 · WITHDRAWN · sponsor: **University of Medicine and Dentistry of New Jersey**

## Conditions studied

- Hyperglycemia
- Leukemia

## Interventions

- **BIOLOGICAL:** insulin glargine recombinant
- **DRUG:** therapeutic insulin

## Key facts

- **NCT ID:** NCT00943709
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of accrual
- **Last updated:** 2013-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943709, "Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00943709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*